Shemesh Shay (CIK 1896056) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-01-09). Recent activity: Buy NVCT (150,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-09 | Nuvectis Pharma, Inc. (NVCT) | Chief Dev. & Ops. Officer | Buy | 150,000 | $0 |
Source: SEC Form 4 filings · as of 2026-01-09